Activity Number
Title
Sponsor(s)
Type
Location
CE_03C
Analysis of Clinical Trials: Theory and Applications
ASA
Biopharmaceutical Section
Professional Development Continuing Education Course
Sat, 8/2
8:30 AM to
5:00 PM
Room: CC-160B
13
*
Statistical Challenges for Cancer Clinical Trials
Biopharmaceutical Section
Statistics Without Borders
International Indian Statistical Association
Topic Contributed Papers
Sun, 8/3
2:00 PM to
3:50 PM
Room: CC-257B
21
*
Patient Monitoring and Adaptive Intervention in Clinical Quality Improvement
Biopharmaceutical Section
Topic Contributed Papers
Sun, 8/3
2:00 PM to
3:50 PM
Room: CC-254B
30
*
Adaptive Designs for Early Phase Studies
Biopharmaceutical Section
Contributed Papers
Sun, 8/3
2:00 PM to
3:50 PM
Room: CC-254A
31
*
Power and Sample Size
Biopharmaceutical Section
Contributed Papers
Sun, 8/3
2:00 PM to
3:50 PM
Room: CC-258C
46
* !
Data-Monitoring Committees: Do They Have Role in Post-Marketing Approval Commitments?
Biopharmaceutical Section
Section on Medical Devices and Diagnostics
Scientific and Public Affairs Advisory Committee
Invited Papers
Sun, 8/3
4:00 PM to
5:50 PM
Room: CC-258A
63
* !
Missing Data in Safety Evaluation and Observational Studies
Biopharmaceutical Section
Topic Contributed Papers
Sun, 8/3
4:00 PM to
5:50 PM
Room: CC-260
66
* !
Enrollment and Event Projection in Clinical Trials
Social Statistics Section
Biopharmaceutical Section
Topic Contributed Papers
Sun, 8/3
4:00 PM to
5:50 PM
Room: CC-157B
72
*
Biomarkers and Endpoint Validation 1
Biopharmaceutical Section
Contributed Papers
Sun, 8/3
4:00 PM to
5:50 PM
Room: CC-208
73
*
Randomization and Covariate Adjustment
Biopharmaceutical Section
Contributed Papers
Sun, 8/3
4:00 PM to
5:50 PM
Room: CC-209
210653
Biopharmaceutical Section Executive Committee Meeting
Biopharmaceutical Section
Other Cmte/Business
Mon, 8/4
7:30 AM to
12:00 PM
Room: S-Seaport Ballroom C
113
Go/No-Go: The Practice for Developing Best-in-Class Product from Statistical Perspective
Biopharmaceutical Section
Topic Contributed Papers
Mon, 8/4
8:30 AM to
10:20 AM
Room: CC-257B
114
* !
Statistical Issues in Process Validation of Pharmaceutical Products
Biopharmaceutical Section
Section on Physical and Engineering Sciences
Topic Contributed Papers
Mon, 8/4
8:30 AM to
10:20 AM
Room: CC-257A
127
*
Bayesian Designs in Clinical Trials
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
Contributed Papers
Mon, 8/4
8:30 AM to
10:20 AM
Room: CC-258C
128
*
Statistical Methods for Early Stopping and Go/No-Go Decision
Biopharmaceutical Section
Contributed Papers
Mon, 8/4
8:30 AM to
10:20 AM
Room: CC-258B
CE_14C
Design and Analysis of Noninferiority Trials
ASA
Biopharmaceutical Section
Professional Development Continuing Education Course
Mon, 8/4
8:30 AM to
5:00 PM
Room: CC-162AB
149
* !
Global Development of Biopharmaceutical Products: Past, Present and Future
Biopharmaceutical Section
Section on Medical Devices and Diagnostics
Invited Papers
Mon, 8/4
10:30 AM to
12:20 PM
Room: CC-257B
157
* !
Impact of Statistics on Imaging Studies in Drug Development
Biopharmaceutical Section
Section on Statistics in Imaging
Topic Contributed Papers
Mon, 8/4
10:30 AM to
12:20 PM
Room: CC-213
167
Speed Session #2: Topics in Biopharmaceutical Research and Statistical Programming and Analysis, Part 1
Section for Statistical Programmers and Analysts
Biopharmaceutical Section
Contributed Speed
Mon, 8/4
10:30 AM to
12:20 PM
Room: CC-255
172
*
Statistical Methods in Oncology Trials
Biopharmaceutical Section
Contributed Papers
Mon, 8/4
10:30 AM to
12:20 PM
Room: CC-259A
173
*
Biopharmaceutical Section Student Paper Competition
Biopharmaceutical Section
Contributed Papers
Mon, 8/4
10:30 AM to
12:20 PM
Room: CC-260
217
*
The Role of Statisticians in Risk-Based Monitoring and Fraud Detection in Clinical Trials
Biopharmaceutical Section
Topic Contributed Papers
Mon, 8/4
2:00 PM to
3:50 PM
Room: CC-257B
222
* !
Showcasing the Application of Bayesian Methods in Drug Development via Case Studies
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
Topic Contributed Papers
Mon, 8/4
2:00 PM to
3:50 PM
Room: CC-254A
233
*
Meta-Analysis in Biopharmaceutical Research
Biopharmaceutical Section
Contributed Papers
Mon, 8/4
2:00 PM to
3:50 PM
Room: CC-254B
234
*
Subgroup Analysis and Biomarkers
Biopharmaceutical Section
Contributed Papers
Mon, 8/4
2:00 PM to
3:50 PM
Room: CC-258C
245
Speed Session #2: Topics in Biopharmaceutical Statistics and Programming and Analysis, Part 2
Biopharmaceutical Section
Section for Statistical Programmers and Analysts
Contributed Poster Presentations
Mon, 8/4
2:00 PM to
2:45 PM
Room: CC-Exhibit Hall B2
269
* !
Statisticians' Contributions to Public Health Achievements of the 20th Century
Biopharmaceutical Section
Scientific and Public Affairs Advisory Committee
ASA 175th Anniversary Steering Committee
Committee on ASA Archives and Historical Materials
Invited Papers
Tue, 8/5
8:30 AM to
10:20 AM
Room: CC-151A
277
* !
Designs and Analyses of Studies with Small Sample Sizes
Biopharmaceutical Section
Topic Contributed Papers
Tue, 8/5
8:30 AM to
10:20 AM
Room: CC-153A
280
* !
Learning to Use and Love Analysis Data Standards
Biopharmaceutical Section
Education Workgroup on Undergraduate Curriculum Guidelines
Topic Contributed Papers
Tue, 8/5
8:30 AM to
10:20 AM
Room: CC-153C
293
*
Dose Finding, Dose Range, and Oncology Trials
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
8:30 AM to
10:20 AM
Room: CC-151B
305
*
Statistical Issues in Drug Development and Labeling
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
8:30 AM to
10:20 AM
Room: CC-156C
CE_22C
Genomic Clinical Trials and Predictive Medicine
ASA
Biopharmaceutical Section
Professional Development Continuing Education Course
Tue, 8/5
8:30 AM to
5:00 PM
Room: CC-162AB
319
*
Impact of Missing Data on Trial Success and Approval of Potentially Efficacious Therapies
Biopharmaceutical Section
Topic Contributed Papers
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-156A
330
*
Advancing Oncology Drug Development Using Biomarker and Surrogate Endpoints
Biopharmaceutical Section
Topic Contributed Papers
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-156C
331
Speed Session #5: Topics in Nonparametric and Biopharmaceutical Statistics, Part 1
Biopharmaceutical Section
Section on Nonparametric Statistics
Contributed Speed
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-255
335
*
Assessing Biosimilar and Equivalence
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-153B
336
*
Modeling in Longitudinal Analysis
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-157C
350
Contributed Oral Poster Presentations: Biopharmaceutical Section
Biopharmaceutical Section
Contributed Poster Presentations
Tue, 8/5
10:30 AM to
12:20 PM
Room: CC-Exhibit Hall B2
377
* !
Optimizing Drug Development Programs and Portfolios: Beyond Adaptive Design
Biopharmaceutical Section
Topic Contributed Papers
Tue, 8/5
2:00 PM to
3:50 PM
Room: CC-252B
385
* !
Impacts of Emerging Global Clinical Trials Transparency Initiatives
Biopharmaceutical Section
Section on Medical Devices and Diagnostics
Topic Contributed Papers
Tue, 8/5
2:00 PM to
3:50 PM
Room: CC-251
394
*
Innovative Clinical Trial Design and Analysis Methods
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
2:00 PM to
3:50 PM
Room: CC-258A
395
*
Missing Data Methods 1
Biopharmaceutical Section
Contributed Papers
Tue, 8/5
2:00 PM to
3:50 PM
Room: CC-258B
409
Speed Session #5: Topics in Nonparametric and Biopharmaceutical Statistics, Part 2
Section on Nonparametric Statistics
Biopharmaceutical Section
Contributed Poster Presentations
Tue, 8/5
2:00 PM to
2:45 PM
Room: CC-Exhibit Hall B2
210702
Biopharmaceutical Section Business Meeting
Biopharmaceutical Section
Other Cmte/Business
Tue, 8/5
5:30 PM to
7:00 PM
Room: S-Plaza Ballroom C
422
Biopharmaceutical Section A.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables AM Roundtable Discussion
Wed, 8/6
7:00 AM to
8:15 AM
Room: CC-Ballroom West
429
* !
Statistical Planning of an Adaptive Design in Early Phase Trials
Biopharmaceutical Section
Invited Papers
Wed, 8/6
8:30 AM to
10:20 AM
Room: CC-260
443
*
Sequential Monitoring in Late-Stage Clinical Trials
Biopharmaceutical Section
Topic Contributed Papers
Wed, 8/6
8:30 AM to
10:20 AM
Room: CC-258A
458
*
Sample Size Determination and Mid-Course Adjustment
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
8:30 AM to
10:20 AM
Room: CC-254A
459
*
Multiplicity Adjustment Methods 1
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
8:30 AM to
10:20 AM
Room: CC-257B
484
* !
Bayesian Methods in Global Clinical Trials: An Era of Synthesizing Evidence
Biopharmaceutical Section
International Society for Bayesian Analysis (ISBA)
International Indian Statistical Association
Topic Contributed Papers
Wed, 8/6
10:30 AM to
12:20 PM
Room: CC-252B
492
* !
Approaches for Benefit-Risk Assessment in Clinical Development Decisionmaking
Biopharmaceutical Section
Topic Contributed Papers
Wed, 8/6
10:30 AM to
12:20 PM
Room: CC-254B
500
*
Noninferiority and Equivalence Trials
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
10:30 AM to
12:20 PM
Room: CC-258B
501
*
Methods for Safety, Quality, and Benefit-Risk
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
10:30 AM to
12:20 PM
Room: CC-251
522
Biopharmaceutical Section P.M. Roundtable Discussion (Fee Event)
Biopharmaceutical Section
Roundtables PM Roundtable Discussion
Wed, 8/6
12:30 PM to
1:50 PM
Room: CC-Ballroom West
534
* !
Innovative Designs in Vaccine Clinical Trials
Biopharmaceutical Section
Invited Papers
Wed, 8/6
2:00 PM to
3:50 PM
Room: CC-258A
546
* !
Recent Advances in Covariate-Adaptive Randomization in Clinical Trials: Statistical, Operational, and Regulatory Aspects
Biopharmaceutical Section
Topic Contributed Papers
Wed, 8/6
2:00 PM to
3:50 PM
Room: CC-252A
563
*
Multiplicity Adjustment Methods 2
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
2:00 PM to
3:50 PM
Room: CC-259A
564
*
Modeling, Simulations, Predictions, and Pro for Labeling
Biopharmaceutical Section
Contributed Papers
Wed, 8/6
2:00 PM to
3:50 PM
Room: CC-257A
591
!
Clinical Trials: Innovative Design and Analysis Ideas for Improving Efficiency
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/7
8:30 AM to
10:20 AM
Room: CC-258A
592
*
Design and Analysis of Large Outcomes Trials
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/7
8:30 AM to
10:20 AM
Room: CC-254B
605
*
Adaptive Designs for Clinical Trials and Observational Studies
Biopharmaceutical Section
Contributed Papers
Thu, 8/7
8:30 AM to
10:20 AM
Room: CC-254A
606
*
Biomarkers and Endpoint Validation 2
Biopharmaceutical Section
Contributed Papers
Thu, 8/7
8:30 AM to
10:20 AM
Room: CC-252B
625
*
Heart Failure Trials: Novel Estimands and Methodologies to Evaluate Therapies Based on the Totality of Evidence
Biopharmaceutical Section
Invited Papers
Thu, 8/7
10:30 AM to
12:20 PM
Room: CC-260
631
* !
Evidential Approaches to Multiplicity of Hypothesis Testing
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/7
10:30 AM to
12:20 PM
Room: CC-254A
632
*
Biomarkers in Clinical Trials and the Regulatory Environment
Biopharmaceutical Section
Topic Contributed Papers
Thu, 8/7
10:30 AM to
12:20 PM
Room: CC-254B
646
*
Missing Data Methods 2
Biopharmaceutical Section
Contributed Papers
Thu, 8/7
10:30 AM to
12:20 PM
Room: CC-252B
657
*
Analysis of Cut Point and Correlated Data
Biopharmaceutical Section
Contributed Papers
Thu, 8/7
10:30 AM to
12:20 PM
Room: CC-257B
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Copyright © American Statistical Association.